Publications

  1. Neural multiplexing vs place coding: Multiplexing steps in when most needed Leeman, J.M., Willett, S.M., Marco, N., et al. bioRxiv preprint, 2026.
  2. Adaptive Generalized Elliptical Slice Sampling Marco, N., Tokdar, S.T. arXiv preprint, 2026.
  3. Mixed Membership Models for Multilevel Functional Data Telesca, D., Marco, N., Landry, E. arXiv preprint, 2026.
  4. Covariate Adjusted Functional Mixed Membership Models Marco, N., Şentürk, D., Jeste, S., et al. Statistics and Data Science in Imaging, 2025.
  5. Germline microRNA-based signatures predict toxicity and response to anti-CTLA-4 therapy Weidhaas, J.B., McGreevy, K.M., Marco, N., et al. Journal of Translational Medicine, 2025.
  6. Bayesian Covariance Regression in Functional Data Analysis with Applications to Functional Brain Imaging Shamshoian, J., Marco, N., Şentürk, D., et al. The International Journal of Biostatistics, 2025.
  7. Modeling Neural Switching via Drift-Diffusion Models Marco, N., Groh, J.M., Tokdar, S.T. arXiv preprint, 2024.
  8. Flexible Regularized Estimation in High-Dimensional Mixed Membership Models Marco, N., Şentürk, D., Jeste, S., et al. Computational Statistics & Data Analysis, 2024.
  9. Functional Mixed Membership Models Marco, N., Şentürk, D., Jeste, S., et al. Journal of Computational and Graphical Statistics, 2024.
  10. Early findings from the GARUDA trial: The impact of a genetic signature of late radiation toxicity on prostate cancer treatment decision making Weidhaas, J.B., Marco, N., Steinberg, M.L., et al. Journal of Clinical Oncology, 2023.
  11. Application of a genetic signature of late GU toxicity in SCIMITAR, a Post-op SBRT trial Kishan, A.U., Marco, N., Ma, T.M., et al. Clinical and Translational Radiation Oncology, 2023.
  12. Viral burden and clearance in asymptomatic COVID-19 Patients Gunatilaka, A.B., Marco, N., Read, G.H., et al. Open forum infectious diseases, 2022.
  13. Germline biomarkers predict toxicity to anti-PD1/PDL1 checkpoint therapy Weidhaas, J., Marco, N., Scheffler, A.W., et al. Journal for immunotherapy of cancer, 2022.
  14. Germline variants disrupting microRNAs predict long-term genitourinary toxicity after prostate cancer radiation Kishan, A.U., Marco, N., Schulz-Jaavall, M.B., et al. Radiotherapy and Oncology, 2022.